The estimated Net Worth of Ventures Iii, Llc Versant V... is at least 191 千$ dollars as of 8 June 2016. Ventures V owns over 714,285 units of Flexion Therapeutics Inc stock worth over 190,591$ and over the last 8 years Ventures sold FLXN stock worth over 0$.
Ventures has made over 2 trades of the Flexion Therapeutics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Ventures bought 714,285 units of FLXN stock worth 9,999,990$ on 8 June 2016.
The largest trade Ventures's ever made was buying 714,285 units of Flexion Therapeutics Inc stock on 8 June 2016 worth over 9,999,990$. On average, Ventures trades about 714,285 units every 0 days since 2016. As of 8 June 2016 Ventures still owns at least 20,739 units of Flexion Therapeutics Inc stock.
You can see the complete history of Ventures V stock trades at the bottom of the page.
Ventures's mailing address filed with the SEC is 1 Sansome St # 2000, San Francisco, CA 94104, USA.
Over the last 11 years, insiders at Flexion Therapeutics Inc have traded over 7,066,621$ worth of Flexion Therapeutics Inc stock and bought 7,091,809 units worth 98,920,816$ . The most active insiders traders include Holdings A/S Novo、Bradley J Ph D Bolzon、Samuel D Colella. On average, Flexion Therapeutics Inc executives and independent directors trade stock every 24 days with the average trade being worth of 609,564$. The most recent stock trade was executed by Christina Willwerth on 19 July 2021, trading 3,945 units of FLXN stock currently worth 25,445$.
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.
Flexion Therapeutics Inc executives and other stock owners filed with the SEC include: